Hormone replacement therapy and breast cancer risk.
Gambrell
R D
RD
Department of Physiology and Endocrinology, Medical College of Georgia, Augusta, USA.
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D016889:Endometrial Neoplasms / Q000453:epidemiology; D004958:Estradiol / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000453:epidemiology; D011374:Progesterone / Q000627:therapeutic use*; D011379:Prognosis; D012307:Risk Factors; D018426:SEER Program; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology
D011374:Progesterone; D004958:Estradiol